As for the immunoregulatory profile, DCs from pediatric patients with T1D showed higher expression of PPARG and TGFB1—two genes downstream in the efferocytosis signaling pathway—than control subjects. This evidence concerns the gene PPARG and type 1 diabetes mellitus.